Followers | 1323 |
Posts | 247,905 |
Boards Moderated | 57 |
Alias Born | 12/07/2009 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$GNPX #Bullish #Nasdaq $2.61 +4.91% Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer | NASDAQ https://www.nasdaq.com/press-release/genprex-doses-first-patient-in-acclaim-3-clinical-study-of-reqorsar-immunogene
$GNPX #Bullish #Nasdaq $2.61 +4.91% Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer | NASDAQ https://www.nasdaq.com/press-release/genprex-doses-first-patient-in-acclaim-3-clinical-study-of-reqorsar-immunogene
$CCTG 🔥 huge upside potential
$CCTG 🔥 huge upside potential
Mr. Kung Lok Chiu, Chief Executive Officer and Director of the Company, commented, "As part of our on-going strategic plan, we will continue to widen our strategic moat by investing in supply chain infrastructure to further enhance the agility and resiliency of our business. We believe our new Center will better support our business by driving long-term growth. This initiative is also crucial in our endeavors to become a leader in the interconnect products market. We are committed to adopting the most advanced technologies, developing replicable and scalable solutions, and fostering innovative ideas and products." $CCTG
$IVDN: Our patented Insultex House Wrap (TM) can make a real contribution to carbon reduction with its R-6 Rating, unmatched by any competitive product. A unique evacuated cell design makes this possible. Better Insulation = Less demand from carbon emitting energy suppliers.
Improving residential insulation and modifying heat-use behaviors using incentives could reduce carbon dioxide emissions in the United States by more than 2 million metric tons per year, finds a new @ScienceAdvances study. https://t.co/rEORrwEmcq pic.twitter.com/f1uxuN4Ler
— Science Magazine (@ScienceMagazine) April 7, 2024
$CCTG NEWS #Nasdaq - Link to company news on website: https://ccsctechnology.gcs-web.com/news-releases/news-release-details/ccsc-technology-international-holdings-limited-announces-plan
$NRXP $3.55 +9.90% @NRxPharma Reports 1st Quarter 2024 Financial Results and Provides Business Update & 2024 Catalysts: Positive Clinical Data, Two Planned NDAs, Company Launch of Hope Therapeutics; FDA QIDP award in cUTI and New Schizophrenia Opportunity https://ir.nrxpharma.com/index.php?s=43&item=237
$NRXP $3.55 +9.90% @NRxPharma Reports 1st Quarter 2024 Financial Results and Provides Business Update & 2024 Catalysts: Positive Clinical Data, Two Planned NDAs, Company Launch of Hope Therapeutics; FDA QIDP award in cUTI and New Schizophrenia Opportunity https://ir.nrxpharma.com/index.php?s=43&item=237
$CCTG NEWS: CCSC Technology International Holdings Limited Announces Plan for New Supply Chain Management Center in Central Europe
Thu, May 16, 2024, 8:00 AM EDT
In this article: $CCTG -CCSC Technology International Holdings Limited
Hong Kong, May 16, 2024 (GLOBE NEWSWIRE) -- CCSC Technology International Holdings Limited (the “Company” or “CCSC”) (Nasdaq: CCTG), a Hong Kong-based company that engages in the sale, design and manufacturing of interconnect products, including connectors, cables and wire harnesses, today announced that the Company plans to commence construction of a new Europe supply chain management center (the “Center”) located in Municipality of Merosina, Republic of Serbia (“Serbia”), in August 2024. The 50,000-square-meter facility will be CCSC’s first supply chain center project and is scheduled for completion in 2025. Once completed, it will serve as the headquarters of the Company's supply chain operations in Europe.
To further optimize production efficiency and boost synergy, in February 2024, CCSC formed a new subsidiary, CCSC Technology Doo Beograd, in Belgrade, Serbia. This subsidiary will be responsible for the operations of our new Europe supply chain management. The Company plans to adopt modern automation solutions and three-dimensional storage technology to optimize the use of the storage space, and leverage the latest digital technologies to build a smart supply chain management platform at the Center. The facility will serve as a key integrated supply chain transit hub, supporting the Company's operations across Europe.
This project is fully supported by the Merosina government, with a signed memorandum of understanding marking the collaboration between CCSC Technology Doo Beograd and the Municipality of Merosina. The total investment for the Center is estimated at US$6 million.
Mr. Kung Lok Chiu, Chief Executive Officer and Director of the Company, commented, "As part of our on-going strategic plan, we will continue to widen our strategic moat by investing in supply chain infrastructure to further enhance the agility and resiliency of our business. We believe our new Center will better support our business by driving long-term growth. This initiative is also crucial in our endeavors to become a leader in the interconnect products market. We are committed to adopting the most advanced technologies, developing replicable and scalable solutions, and fostering innovative ideas and products."
About CCSC Technology International Holdings Limited
CCSC Technology International Holdings Limited, is a Hong Kong-based company that engages in the sale, design and manufacturing of interconnect products. The Company specializes in customized interconnect products, including connectors, cables and wire harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. The Company produces both OEM (“original equipment manufacturer”) and ODM (“original design manufacture”) interconnect products for manufacturing companies that produce end products, as well as electronic manufacturing services (“EMS”) companies that procure and assemble products on behalf of such manufacturing companies. The Company has a diversified global customer base located in more than 25 countries throughout Asia, Europe and the Americas. For more information, please visit the Company’s website: http://ir.ccsc-interconnect.com.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements, including, but not limited to, the Company's proposed Offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “may,” “will,” “could,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “propose,” “potential,” “continue”, or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the U.S. Securities and Exchange Commission.
For more information, please contact:
CCSC Technology International Holdings Limited
Investor Relations Department
Email: ir@ccsc-interconnect.com
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
NEWS: $CCTG -CCSC Technology International Holdings Limited Announces Plan for New Supply Chain Management Center in Central Europe
Thu, May 16, 2024, 8:00 AM EDT
In this article: $CCTG -CCSC Technology International Holdings Limited
Hong Kong, May 16, 2024 (GLOBE NEWSWIRE) -- CCSC Technology International Holdings Limited (the “Company” or “CCSC”) (Nasdaq: CCTG), a Hong Kong-based company that engages in the sale, design and manufacturing of interconnect products, including connectors, cables and wire harnesses, today announced that the Company plans to commence construction of a new Europe supply chain management center (the “Center”) located in Municipality of Merosina, Republic of Serbia (“Serbia”), in August 2024. The 50,000-square-meter facility will be CCSC’s first supply chain center project and is scheduled for completion in 2025. Once completed, it will serve as the headquarters of the Company's supply chain operations in Europe.
To further optimize production efficiency and boost synergy, in February 2024, CCSC formed a new subsidiary, CCSC Technology Doo Beograd, in Belgrade, Serbia. This subsidiary will be responsible for the operations of our new Europe supply chain management. The Company plans to adopt modern automation solutions and three-dimensional storage technology to optimize the use of the storage space, and leverage the latest digital technologies to build a smart supply chain management platform at the Center. The facility will serve as a key integrated supply chain transit hub, supporting the Company's operations across Europe.
This project is fully supported by the Merosina government, with a signed memorandum of understanding marking the collaboration between CCSC Technology Doo Beograd and the Municipality of Merosina. The total investment for the Center is estimated at US$6 million.
Mr. Kung Lok Chiu, Chief Executive Officer and Director of the Company, commented, "As part of our on-going strategic plan, we will continue to widen our strategic moat by investing in supply chain infrastructure to further enhance the agility and resiliency of our business. We believe our new Center will better support our business by driving long-term growth. This initiative is also crucial in our endeavors to become a leader in the interconnect products market. We are committed to adopting the most advanced technologies, developing replicable and scalable solutions, and fostering innovative ideas and products."
About CCSC Technology International Holdings Limited
CCSC Technology International Holdings Limited, is a Hong Kong-based company that engages in the sale, design and manufacturing of interconnect products. The Company specializes in customized interconnect products, including connectors, cables and wire harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. The Company produces both OEM (“original equipment manufacturer”) and ODM (“original design manufacture”) interconnect products for manufacturing companies that produce end products, as well as electronic manufacturing services (“EMS”) companies that procure and assemble products on behalf of such manufacturing companies. The Company has a diversified global customer base located in more than 25 countries throughout Asia, Europe and the Americas. For more information, please visit the Company’s website: http://ir.ccsc-interconnect.com.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements, including, but not limited to, the Company's proposed Offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “may,” “will,” “could,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “propose,” “potential,” “continue”, or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the U.S. Securities and Exchange Commission.
For more information, please contact:
CCSC Technology International Holdings Limited
Investor Relations Department
Email: ir@ccsc-interconnect.com
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
(OTC-BB: $TREIF) (CNSX: TRUE.CN) Artificial Intelligence Enabled Technologies Transforming Healthcare Industry Creating Multi-Billion Dollar Opportunities https://barchart.com/share/news/26222888 via
@Barchart Active tech companies in the markets this week include @TreatmentAI
(OTC-BB: $TREIF) (CNSX: TRUE.CN) Artificial Intelligence Enabled Technologies Transforming Healthcare Industry Creating Multi-Billion Dollar Opportunities https://barchart.com/share/news/26222888 via
@Barchart Active tech companies in the markets this week include @TreatmentAI
$NRXP @AP #NEWS Positive Q1 Results Posted After Clinical Trial Delivers Statistically-Significant Data for Bipolar: NRx: Nasdaq: NRXP https://apnews.com/press-release/ein-presswire-newsmatics/pain-management-651a2712dea09212b35d108b356e83a2?utm_source=twitter&utm_medium=share
$NRXP @AP #NEWS Positive Q1 Results Posted After Clinical Trial Delivers Statistically-Significant Data for Bipolar: NRx: Nasdaq: NRXP https://apnews.com/press-release/ein-presswire-newsmatics/pain-management-651a2712dea09212b35d108b356e83a2?utm_source=twitter&utm_medium=share
$GMPR Gourmet Provisions International Corp. (GMPR) Announces Licensing Discussions with Aerosolization Equity Investments, LLC | NASDAQ https://www.nasdaq.com/press-release/gourmet-provisions-international-corp.-gmpr-announces-licensing-discussions-with
$GMPR Gourmet Provisions International Corp. (GMPR) Announces Licensing Discussions with Aerosolization Equity Investments, LLC | NASDAQ https://www.nasdaq.com/press-release/gourmet-provisions-international-corp.-gmpr-announces-licensing-discussions-with
OTC: $TREIF CSE: $TRUE Treatment.com AI and Novus Health Partnership Expands Access to its Global Library of Medicine (GLM) | NASDAQ https://www.nasdaq.com/press-release/treatment.com-ai-and-novus-health-partnership-expands-access-to-its-global-library-of
OTC: $TREIF CSE: $TRUE Treatment.com AI and Novus Health Partnership Expands Access to its Global Library of Medicine (GLM) | NASDAQ https://www.nasdaq.com/press-release/treatment.com-ai-and-novus-health-partnership-expands-access-to-its-global-library-of
$NCL .42 HOD .4488 @Northann_Corp Announces Strategic Partnership with Adornus Cabinetry | NASDAQ https://www.nasdaq.com/press-release/northann-corp.-announces-strategic-partnership-with-adornus-cabinetry-2024-05-14 $BLIS $ACGX $S
$NCL .42 HOD .4488 @Northann_Corp Announces Strategic Partnership with Adornus Cabinetry | NASDAQ https://www.nasdaq.com/press-release/northann-corp.-announces-strategic-partnership-with-adornus-cabinetry-2024-05-14 $BLIS $ACGX $S
$NRXP $3.21 +1.09% HOD $3.25 - NRXP 2024 Catalysts: Positive Clinical Data, Two Planned NDAs, Company Launch of Hope Therapeutics; FDA QIDP award in cUTI and New Schizophrenia Opportunity https://www.nasdaq.com/press-release/nrx-pharmaceuticals-nasdaq:nrxp-reports-first-quarter-2024-financial-results-and
$NRXP $3.21 +1.09% HOD $3.25 NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update | NASDAQ @NRxPharma https://www.nasdaq.com/press-release/nrx-pharmaceuticals-nasdaq:nrxp-reports-first-quarter-2024-financial-results-and $GNPX $RENB $BLIS
$GNPX trial aims to determine the safety and optimal dosage of Reqorsa™ https://finance.yahoo.com/news/genprex-dosing-subjects-trial-combination-084204787.html
$GNPX trial aims to determine the safety and optimal dosage of Reqorsa™ https://finance.yahoo.com/news/genprex-dosing-subjects-trial-combination-084204787.html
$GNPX @Genprex has enrolled and dosed the first subject in a Phase I/II trial to assess a combination therapy for extensive-stage small cell lung cancer (ES-SCLC). The Acclaim-3 trial aims to determine the safety and optimal dosage of Reqorsa™ https://finance.yahoo.com/news/genprex-dosing-subjects-trial-combination-084204787.html
$GNPX @Genprex has enrolled and dosed the first subject in a Phase I/II trial to assess a combination therapy for extensive-stage small cell lung cancer (ES-SCLC). The Acclaim-3 trial aims to determine the safety and optimal dosage of Reqorsa™ https://finance.yahoo.com/news/genprex-dosing-subjects-trial-combination-084204787.html
$NRPX $RENB
$BLIS Daily Chart 5 day change +23.68% 1-month change 72.34% 6 months +202.52% YTD 637.72%
https://tradingview.com/symbols/OTC-BLIS/
$BLIS Daily Chart 5 day change +23.68% 1-month change 72.34% 6 months +202.52% YTD 637.72%
https://tradingview.com/symbols/OTC-BLIS/
$ACGX Alliance Creative Group, Inc., http://www.acgx.us (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Quarter Ending March 31, 2024. The total assets on the Balance Sheet as of 3/31/24 were $4,531,689 https://www.nasdaq.com/press-release/alliance-creative-group-acgx-releases-q1-2024-financial-and-disclosure-report-with-an $NRPX $RENB
$ACGX Alliance Creative Group, Inc., http://www.acgx.us (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Quarter Ending March 31, 2024. The total assets on the Balance Sheet as of 3/31/24 were $4,531,689 https://www.nasdaq.com/press-release/alliance-creative-group-acgx-releases-q1-2024-financial-and-disclosure-report-with-an $NRPX $RENB
$NCL Northann Corp. (NYSE: NCL) #HotStock #3DPrinting ECO Friendly 3D-Printed Flooring & Wall Panel Products Made Using Recycled Ocean Plastics For more information on NCL, visit: https://icont.ac/4Yp5Z
$NCL Northann Corp. (NYSE: NCL) #HotStock #3DPrinting ECO Friendly 3D-Printed Flooring & Wall Panel Products Made Using Recycled Ocean Plastics For more information on NCL, visit: https://icont.ac/4Yp5Z
$NCL .41 HOD .4488 on Seekingalpha.com as Northann Corp. Announced yesterday its Strategic Partnership with Adornus Cabinetry https://seekingalpha.com/pr/19724039-northann-corp-announces-strategic-partnership-adornus-cabinetry?source=tweet @Northann_Corp @NYSE
$GNPX $2.46 HOD $2.54 @GMan Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer https://seekingalpha.com/pr/19724315-genprex-doses-first-patient-in-acclaimminus-3-clinical-study-of-reqorsa-immunogene-therapy-in?source=tweet #BreakingNews #FDA $BMY $JNJ
$GNPX $2.46 HOD $2.54 @GMan Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer https://seekingalpha.com/pr/19724315-genprex-doses-first-patient-in-acclaimminus-3-clinical-study-of-reqorsa-immunogene-therapy-in?source=tweet #BreakingNews #FDA $BMY $JNJ
$BURU .133 +1.22%
@NUBURUlasers
Enters Medical Device Market with Order from European Manufacturer https://seekingalpha.com/pr/19726368-nuburu-enters-medical-device-market-order-from-european-manufacturer?source=tweet #News #Out
$BURU .133 +1.22%
@NUBURUlasers
Enters Medical Device Market with Order from European Manufacturer https://seekingalpha.com/pr/19726368-nuburu-enters-medical-device-market-order-from-european-manufacturer?source=tweet #News #Out